“Clinicians are encouraged to consider testing for other causes of respiratory illness such as influenza, in addition to testing for SARS-CoV-2” – CDC
Acute respiratory infection remains the leading cause of death amongst geriatric and immuno-compromised patients. For infectious diseases that interfere with normal breathing, it is essential to detect multiple pathogens simultaneously.
Make clinical decisions on a wide array of infections
Reduce the time to treatment
Target and personalize therapy
With our newest test, SARS-CoV-2/COVID-19 with Influenza Profile, PCR test (P10012), MHS Labs can detect and differentiate RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper respiratory specimens at the same time.
The tests can be ordered as individual order choices and combination or reflex panels using the same specimen/swab and most accurate PCR method without compromising the targeted 24-48 hour COVID-19 test turnaround times.